スポンサーリンク
Department Of Hematology And Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki Universi | 論文
- Randomized trial of cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil with node-positive breast cancer in Japan
- Phase II study of oral fludarabine in combination with rituximab for relapsed indolent B-cell non-Hodgkin lymphoma
- Phase I/II and pharmacokinetic study of cladribine with 2-h infusion in Japanese patients with relapsed indolent B-cell lymphoma mostly pretreated with rituximab
- Incidence of Diffuse Large B-Cell Lymphoma of Germinal Center B-Cell Origin in Whole Diffuse Large B-Cell Lymphoma : Tissue Fluorescence In Situ Hybridization Using t(14 ; 18) Compared with Immunohistochemistry
- Epstein-Barr Virus-Associated Composite Lymphoma Composed of Peripheral T-Cell Lymphoma and an Anaplastic Variant of a Diffuse Large B-Cell Type of Non-Hodgkin's Lymphoma and Strongly Expressing p53 Protein
- Epstein-Barr Virus-Associated Anaplastic Large Cell Variant of Diffuse Large B-Cell-Type Non-Hodgkin's Lymphoma with Concurrent p53 Protein Expression
- IgD monoclonal gammopathy of undetermined significance
- Primary carcinoid of the testis associated with carcinoid syndrome
- Transgene Insertion Pattern Analysis Using Genomic Walking in a Transgenic Mouse Line
- Sharing of receptor subunits and signal transduction pathway between the IL-4 and IL-13 receptor system
- Phase II study of 4-weekly capecitabine monotherapy in advanced/metastatic breast cancer
- 遺伝性乳癌・卵巣癌の遺伝子診断および研究の現状 (特集 婦人科における遺伝性腫瘍の取扱いの実際)
- Phase I study of the oral mammalian target of rapamycin inhibitor everolimus (RAD001) in Japanese patients with relapsed or refractory non-Hodgkin lymphoma
- Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia : the JALSG-ALL97 study
- Modified cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX-M)/ifosfamide, etoposide, and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable, with
- Phase II study of ABVd therapy for newly diagnosed clinical stage II-IV Hodgkin lymphoma : Japan Clinical Oncology Group study (JCOG 9305)
- Bortezomib for post-allogeneic hematopoietic stem transplantation relapse and GVHD in multiple myeloma : a single institute experience
- Bortezomib plus dexamethasone for relapsed or treatment refractory multiple myeloma : the collaborative study at six institutes in Kyoto and Osaka
- Randomized phase II study of concurrent and sequential combinations of rituximab plus CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone) chemotherapy in untreated indolent B-cell non-Hodgkin lymphoma : 7-year follow-up results
- Phase I and pharmacokinetic study of bendamustine hydrochloride in relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
スポンサーリンク